The fslE homolog, FTL-0439 (fupA/B), mediates siderophore-dependent iron uptake in Francisella tularensis LVS

Infection and Immunity

Volumn 78, Issue 10, 2010, Pages 4276-4285

  Sen, Bhaswati ^a   Meeker, Alexis ^a   Ramakrishnan, Girija ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; IRON; PROTEIN FSLE; PROTEIN FUP A B; SIDEROPHORE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; FRANCISELLA TULARENSIS; GENE DELETION; GENE LOCUS; IRON TRANSPORT; MACROPHAGE; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TULAREMIA;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; BIOLOGICAL TRANSPORT; CELL LINE; FRANCISELLA TULARENSIS; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; IRON; MACROPHAGES; MICE; MICE, INBRED C57BL; SIDEROPHORES; TULAREMIA; VIRULENCE;

EID: 77957730038     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00503-10     Document Type: Article

References (24)

1. Bagos, P. G., T. D. Liakopoulos, I. C. Spyropoulos, and S. J. Hamodrakas. 2004. PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane proteins. Nucleic Acids Res. 32:W400-W404.
2. Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.
3. Deng, K., R. J. Blick, W. Liu, and E. J. Hansen. 2006. Identification of Francisella tularensis genes affected by iron limitation. Infect. Immun. 74:4224-4236.
4. Eigelsbach, H. T., and C. M. Downs. 1961. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J. Immunol. 87:415-425.
5. Elkins, K. L., S. C. Cowley, and C. M. Bosio. 2003. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 5:135-142.
6. Elkins, K. L., R. K. Winegar, C. A. Nacy, and A. H. Fortier. 1992. Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb. Pathog. 13:417-421.
7. Faraldo-Gomez, J. D., and M. S. P. Sansom. 2003. Acquisition of siderophores in Gram-negative bacteria. Nat. Rev. Mol. Cell Biol. 4:105-116.
8. Kiss, K., W. Liu, J. F. Huntley, M. V. Norgard, and E. J. Hansen. 2008. Characterization of fig operon mutants of Francisella novicida U112. FEMS Microbiol. Lett. 285:270-277.
9. Larsson, P., D. Elfsmark, K. Svensson, P. Wikstrom, M. Forsman, T. Brettin, P. Keim, and A. Johansson. 2009. Molecular evolutionary consequences of niche restriction in Francisella tularensis, a facultative intracellular pathogen. PLoS Pathog. 5:e1000472.
10. Larsson, P., P. C. Oyston, P. Chain, M. C. Chu, M. Duffield, H. H. Fuxelius, E. Garcia, G. Halltorp, D. Johansson, K. E. Isherwood, P. D. Karp, E. Larsson, Y. Liu, S. Michell, J. Prior, R. Prior, S. Malfatti, A. Sjostedt, K. Svensson, N. Thompson, L. Vergez, J. K. Wagg, B. W. Wren, L. E. Lindler, S. G. Andersson, M. Forsman, and R. W. Titball. 2005. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37:153-159.
11. Lindgren, H., M. Honn, I. Golovlev, K. Kadzhaev, W. Conlan, and A. Sjostedt. 2009. The 58-kilodalton major virulence factor of Francisella tularensis is required for efficient utilization of iron. Infect. Immun. 77:4429-4436.
12. Maier, T. M., M. S. Casey, R. H. Becker, C. W. Dorsey, E. M. Glass, N. Maltsev, T. C. Zahrt, and D. W. Frank. 2007. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Infect. Immun. 75:5376-5389.
13. Miethke, M., and M. A. Marahiel. 2007. Siderophore-based iron acquisition and pathogen control. Microbiol. Mol. Biol. Rev. 71:413-451.
14. Noinaj, N., M. Guillier, T. J. Barnard, and S. K. Buchanan. 26 April 2010, posting date. TonB-dependent transporters: regulation, structure, and function. Annu. Rev. Microbiol. [Epub ahead of print.]
15. Pechous, R. D., T. R. McCarthy, and T. C. Zahrt. 2009. Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol. Mol. Biol. Rev. 73:684-711.
16. Ramakrishnan, G., A. Meeker, and B. Dragulev. 2008. fslE is necessary for siderophore-mediated iron acquisition in Francisella tularensis Schu S4. J. Bacteriol. 190:5353-5361.
17. Ratledge, C., and L. G. Dover. 2000. Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol. 54:881-941.
18. Rohmer, L., M. Brittnacher, K. Svensson, D. Buckley, E. Haugen, Y. Zhou, J. Chang, R. Levy, H. Hayden, M. Forsman, M. Olson, A. Johansson, R. Kaul, and S. I. Miller. 2006. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison. Infect. Immun. 74:6895-6906.
19. Salomonsson, E., K. Kuoppa, A. L. Forslund, C. Zingmark, I. Golovliov, A. Sjostedt, L. Noppa, and A. Forsberg. 2009. Reintroduction of two deleted virulence loci restores full virulence to the live vaccine strain of Francisella tularensis. Infect. Immun. 77:3424-3431.
20. Schwyn, B., and J. B. Neilands. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56.
21. Sjöstedt, A. 2006. Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microbes Infect. 8:561-567. (Pubitemid 43214620)
22. Sjöstedt, A. 2007. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann. N. Y. Acad. Sci. 1105:1-29.
23. Sullivan, J. T., E. F. Jeffery, J. D. Shannon, and G. Ramakrishnan. 2006. Characterization of the siderophore of Francisella tularensis and role of fslA in siderophore production. J. Bacteriol. 188:3785-3795.
24. Twine, S., M. Bystrom, W. Chen, M. Forsman, I. Golovliov, A. Johansson, J. Kelly, H. Lindgren, K. Svensson, C. Zingmark, W. Conlan, and A. Sjostedt. 2005. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect. Immun. 73:8345-8352.